Clinical Trial Update: Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of DW9801 in patients with primary dysmenorrhea is in progress (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• DW9801

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Primary Dysmenorrhea | Phase 3 | Status: UNKNOWN